ENSC — Ensysce Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Ensysce Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K/A	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	1.06	0.049	12.3	3.15	1.12
Net Total Accounts Receivable
Net Total Receivables	0.139	0.02	0.442	0.277	0.098
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.2	0.226	15.7	5.3	2.29
Net Property, Plant And Equipment	—	—	0	0	0
Long Term Investments
Other Long Term Assets
Total Assets	197	12.9	16.4	5.89	2.71
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	2.77	0.26	16.5	9.46	3.33
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	10.3	14.1	24.3	9.6	3.03
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	186	-1.21	-7.88	-3.71	-0.323
Total Liabilities & Shareholders' Equity	197	12.9	16.4	5.89	2.71
Total Common Shares Outstanding